1. Home
  2. LEU vs HUMA Comparison

LEU vs HUMA Comparison

Compare LEU & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Centrus Energy Corp.

LEU

Centrus Energy Corp.

BUY

Current Price

$254.13

Market Cap

4.2B

Sector

Industrials

ML Signal

BUY

Logo Humacyte Inc.

HUMA

Humacyte Inc.

HOLD

Current Price

$1.07

Market Cap

236.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LEU
HUMA
Founded
1998
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Mining & Quarrying of Nonmetallic Minerals (No Fuels)
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
236.0M
IPO Year
1998
N/A

Fundamental Metrics

Financial Performance
Metric
LEU
HUMA
Price
$254.13
$1.07
Analyst Decision
Buy
Strong Buy
Analyst Count
12
8
Target Price
$243.00
$10.13
AVG Volume (30 Days)
859.0K
4.3M
Earning Date
02-05-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
31.25
N/A
EPS
6.17
N/A
Revenue
$454,100,000.00
$1,571,000.00
Revenue This Year
$1.17
N/A
Revenue Next Year
$8.96
$698.97
P/E Ratio
$41.22
N/A
Revenue Growth
15.25
N/A
52 Week Low
$49.40
$1.04
52 Week High
$464.25
$5.66

Technical Indicators

Market Signals
Indicator
LEU
HUMA
Relative Strength Index (RSI) 47.40 36.35
Support Level $220.50 $1.04
Resistance Level $281.33 $1.17
Average True Range (ATR) 18.80 0.08
MACD 3.29 -0.01
Stochastic Oscillator 56.98 10.03

Price Performance

Historical Comparison
LEU
HUMA

About LEU Centrus Energy Corp.

Centrus Energy Corp is engaged in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment has two components which include the sale of separative work units and uranium. The Technical Solutions segment provides engineering, design, and manufacturing services to government and private sector customers. The majority of the firm's revenue is derived from the LEU segment. It has a business presence in the U.S. and other countries, of which prime revenue is generated in the U.S.

About HUMA Humacyte Inc.

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: